| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other (expense) income | -5,120 | 147,945 | 3,445 | -5,919 |
| (loss) income before income taxes | -977 | 76,906 | -1,917 | -33,225 |
| Income tax benefit (expense) | -433 | 2,199 | 1,182 | - |
| Net (loss) income | -544 | 74,707 | -3,099 | -33,225 |
| Basic (in dollars per share) | -0.01 | 1.24 | -0.06 | -0.69 |
| Basic (in shares) | 55,951,572 | 54,780,938 | 54,095,543 | 47,808,817 |
| Diluted (in dollars per share) | -0.01 | 1.21 | - | - |
| Diluted (in shares) | 55,951,572 | 56,324,903 | - | - |
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)